Clinical trial
A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant
NCT01468467 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- March 31, 2015
- Enrollment
- 13 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.